• Home
  • About us
    • Our community
      • Members
      • Join All.Can
    • Governance and Funding
      • Board of Directors
      • All.Can Presidents
      • Working groups
      • Structure
    • Collaborations
    • Contact us
  • What we do
    • Resources
      • Policy Research & Evidence
        • NEW global report on person-centred cancer care
        • Action Guide For Efficient Cancer Care
        • All.Can Efficiency Metrics study
        • Achieving efficiency in practice – Lessons learnt from the All.Can Efficiency Hub
        • Policy blueprint: Building efficiency in cancer care
        • Policy report: Harnessing data for better cancer care
        • All.Can international patient survey
        • All.Can’s definition of efficient cancer care
      • Publications
      • COVID-19
      • Videos
    • EU-Funded Projects
    • Efficiency Hub
    • Cancer Policies
  • National initiatives
    • National Initiatives map
    • Become an All.Can national initiative
    • National Initiatives news
  • Events & News
    • Latest news
    • Blog
    • Media coverage
  • Home
  • About us
    • Our community
      • Members
      • Join All.Can
    • Governance and Funding
      • Board of Directors
      • All.Can Presidents
      • Working groups
      • Structure
    • Collaborations
    • Contact us
  • What we do
    • Resources
      • Policy Research & Evidence
        • NEW global report on person-centred cancer care
        • Action Guide For Efficient Cancer Care
        • All.Can Efficiency Metrics study
        • Achieving efficiency in practice – Lessons learnt from the All.Can Efficiency Hub
        • Policy blueprint: Building efficiency in cancer care
        • Policy report: Harnessing data for better cancer care
        • All.Can international patient survey
        • All.Can’s definition of efficient cancer care
      • Publications
      • COVID-19
      • Videos
    • EU-Funded Projects
    • Efficiency Hub
    • Cancer Policies
  • National initiatives
    • National Initiatives map
    • Become an All.Can national initiative
    • National Initiatives news
  • Events & News
    • Latest news
    • Blog
    • Media coverage

All.Can International held its General Assembly and appointed the new Board of Directors

Home News Latest news All.Can International held its General Assembly and appointed the new Board of Directors

 
  • Categories

    • Latest news
    • Press releases
Posted on: 23 May 2023
Share:

Related reading

Publication Announcement: Qualitative Study on the Development of the All.Can Action Guide

A new peer-reviewed article titled “International multi-stakeholder collaboration to support implementation of cancer care efficiency metrics: a qualitative study to develop the All.Can Action Guide” has been published in the journal Health Research Policy and Systems.

The open-access paper details the qualitative research and international multi-stakeholder collaboration that informed the development of the All.Can Action Guide, a tool designed to support the implementation of cancer care efficiency metrics.

Read more

IBTA Releases Report on the Sixth Biennial World Summit of Brain Tumour Patient Advocates 

The International Brain Tumour Alliance (IBTA) has published its official report summarizing the proceedings and outcomes of the Sixth Biennial World Summit of Brain Tumour Patient Advocates, held in Rome, Italy. 

Read more

G7 leaders commit to accelerating the fight against cancer

All.Can International welcomes the call issued yesterday by G7 leaders at the Évian Summit, reaffirming their commitment to accelerate action on cancer and bringing together a broad coalition that includes partner countries Brazil, Egypt, India, Kenya and the Republic of Korea.

Read more

Follow Us

FACEBOOK
X
LINKEDIN
YOUTUBE
Get in touch
CONTACT DETAILS
Join All.Can
APPLY ONLINE
Members' portal
Login

All.Can International is a not-for-profit organisation (ASBL) registered in Belgium. Its work is made possible with financial support from Bristol Myers Squibb, Roche, MSD, Johnson & Johnson, BeOne Medicines, Exact Sciences, and Daiichi-Sankyo, among other funding means.

EU Transparency Register number: 025568638034-92

© Copyright 2026 All.Can

Privacy Policy
Terms & Conditions
Website by Hexagon